Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
Chronic migraine is a disabling neurological disorder characterized by headaches occurring on at least 15 days per month for more than three months. According to Cohen et al. (2024), a systematic review of U.S. population-based studies found that chronic migraine prevalence was 0.91% among adults, including 1.3% among women and 0.5% among men, while prevalence among adolescents was 0.8%. As per the chronic migraine epidemiology forecast by Expert Market Research, epidemiological trends are expected to influence future disease burden and headache management.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
Read more about this report - Request a Free Sample
Chronic Migraine Epidemiology Forecast Report Coverage
Expert Market Research's “Chronic Migraine Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of chronic migraine. It projects the future incidence and prevalence rates of chronic migraine cases across various populations. The study covers age, gender, and type as major determinants of the chronic migraine population. The report highlights patterns in the prevalence of chronic migraine over time and projects future trends based on multiple variables.
The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chronic migraine in the 8 major markets.
Regions Covered
- United States
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
- India
Chronic Migraine Understanding: Disease Overview
Chronic migraine is a disabling primary headache disorder characterized by headache occurring on 15 or more days per month for more than three months, with migraine features on at least eight days per month. It generally develops from episodic migraine as headache frequency increases over time. Symptoms may include moderate-to-severe head pain, nausea, vomiting, and sensitivity to light or sound. Chronic headache may present with migraine with aura or without aura. ICHD-3 also describes forms with continuous pain and those with pain-free periods, reflecting variation in headache patterns.
Key Report Insights
|
Parameter |
Insight |
|
Largest Patient Pool |
United States |
|
Fastest Growing Country |
India |
|
High-Risk Population |
Adults with frequent or longstanding migraine, particularly women of working age |
|
Key Diagnostic Method |
Clinical assessment supported by headache history and headache diary |
|
Major Risk Factor |
High-frequency episodic migraine and medication overuse |
|
Major gap in the market |
Underdiagnosis and undertreatment |
Chronic Migraine Epidemiology Perspective
The chronic migraine epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the chronic migraine epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic migraine and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
|
Epidemiology Segment |
Key Insights |
|
Diagnosed Prevalent Cases of the Disease |
According to Clinical Pain Advisor, chronic migraine affected 1.7% globally, including 2.2% of women and 1.0% of men. As per Frontline Medical Communications Inc., chronic migraine prevalence was 0.91% among United States adults, including 1.3% of women and 0.5% of men. |
|
Gender-Specific Cases of the Disease |
According to Clinical Pain Advisor, chronic migraine prevalence was 2.2% among women compared with 1.0% among men globally. As per Frontline Medical Communications Inc., the corresponding United States adult prevalence was 1.3% among women and 0.5% among men, demonstrating a higher burden among women. |
|
Age-Specific Cases of the Disease |
According to the Herman Ostrow School Of Dentistry OF USC, migraine prevalence typically peaks during the 30s, although chronic migraine may persist or worsen among older adults. According to G. Demarquay et al. (2021), prevalence in France peaked between 35 and 39 years. |
|
Ethnicity-Wise Cases of the Disease |
According to Amaal J. Starling et al. (2025), among U.S. respondents, 61% of Hispanic, 42% of Black, and 49% of White participants reported having received a chronic migraine diagnosis. Black and Hispanic respondents were generally younger than White respondents in the study population. |
|
Mortality and Survival Analysis of the Disease |
According to Shilpi Shukla et al. (2025), migraine ranked second in years lived with disability in the Global Burden of Disease 2016 analysis, highlighting its substantial population-level burden. The provided information primarily addresses disability and prevalence rather than mortality or survival outcomes. |
Read more about this report - Request a Free Sample
Country-wise Chronic Migraine Epidemiology
The chronic migraine epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.
|
Country |
Key Insights |
|
United States |
According to Frontline Medical Communications Inc., migraine prevalence in the United States has remained relatively stable over approximately three decades, ranging from 12% to 15% overall, 17% to 19% among women, and 6% to 7% among men. Chronic migraine affected 0.91% of adults, including 1.3% of women and 0.5% of men, while prevalence among adolescents was 0.8%. |
|
Germany |
According to Andreas Domdey et al. (2026), migraine prevalence in Germany has been reported at approximately 15% among women and 6% among men. In the study population, women represented 87% of participants and men 13%, with many female participants being of childbearing age. |
|
France |
According to G. Demarquay et al. (2021), migraine prevalence in France was 14.4%, with a peak between 35 and 39 years. In this age group, approximately 30% of women and 15% of men were affected. The study also reported that 21.3% of people aged 18 years met the specified diagnostic criteria. |
|
Italy |
As per Centro Dino Ferrari ETS, migraine prevalence among adults in Italy is approximately 12%, with the condition commonly beginning before age 40 and primarily affecting young adults during their peak productive years. The source reported approximately 1.2 million affected people in Lombardy. |
|
Spain |
The epidemiological burden of chronic migraine in Spain is influenced by underdiagnosis, mental health factors, lifestyle patterns, work-related stress, and healthcare utilization. Differences in healthcare access and recognition, together with factors such as psychological well-being, sleep patterns, physical activity, and other comorbid conditions, can contribute to variations in migraine burden across the population. |
|
United Kingdom |
According to The Migraine Trust, migraine affects approximately one in seven people in the United Kingdom, with around one million people living with chronic migraine. The organization also reported differences in migraine-related disclosure concerns and perceived healthcare experiences across gender and ethnic groups. |
|
Japan |
The epidemiological burden of chronic migraine in Japan is influenced by low patient awareness, delayed healthcare-seeking, limited recognition of migraine severity, and barriers to accessing appropriate headache care. Hesitation to seek medical attention and insufficient awareness among patients and healthcare providers may contribute to persistent underrecognition and undertreatment. |
|
India |
According to Kumar et al. (2025), a cross-sectional study of 400 patients with migraine in India found that 57.3% had episodic migraine, while the remaining 42.7% had chronic migraine. The study population was predominantly female (77.3%), with a mean age of 37.2 years. The findings provide recent evidence on the distribution of chronic migraine among patients seeking migraine care in India. |
Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape
A major epidemiological gap in chronic migraine is the underdiagnosis and undertreatment of patients experiencing frequent headache days. Many individuals may remain managed primarily with acute medications despite requiring preventive treatment, while medication overuse can further complicate disease management. Emerging opportunities include improving primary-care recognition, expanding access to headache specialists, encouraging systematic use of headache diaries, and increasing awareness of preventive treatment options. Across the United States, Germany, France, Italy, Spain, the United Kingdom, Japan, and India, improved diagnosis and earlier intervention could support more appropriate disease management and reduce the cumulative burden of chronic migraine.
Chronic Migraine: Treatment Overview
Chronic migraine treatment combines acute management of individual attacks with preventive therapy to reduce headache frequency and severity. Acute options may include triptans, nonsteroidal anti-inflammatory drugs, acetaminophen, and newer migraine-specific therapies when appropriate. Preventive management may include oral preventive medications, onabotulinumtoxinA, and calcitonin gene-related peptide (CGRP)-targeted therapies. Treatment also emphasizes identification and management of triggers, lifestyle modification, and appropriate use of acute medications. Medication-overuse headache should be assessed because frequent use of acute headache medicines can contribute to persistent or worsening headache frequency.
Key Questions Answered
- What is the current and projected burden of chronic migraine across the 8 major markets?
- Which countries across the 8 major markets account for the highest chronic migraine patient populations and fastest growth rates?
- What is the diagnosed versus undiagnosed patient population of chronic migraine across key countries in the 8 major markets?
- Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of chronic migraine across the 8 major markets?
- What are the major drivers contributing to the increasing burden of chronic migraine across the 8 major markets?
- How do major comorbidities and risk factors influence chronic migraine epidemiology trends across the 8 major markets?
- What are the regional trends in advanced disease progression, treatment uptake, and patient management of chronic migraine across the 8 major markets?
- Which patient segments represent the highest unmet clinical need in the chronic migraine landscape across the 8 major markets?
- Which therapeutic areas linked to chronic migraine are expected to witness the strongest growth opportunities across the 8 major markets?
- How is the chronic migraine epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
- Which countries across the 8 major markets offer the most attractive market opportunities based on chronic migraine epidemiology and healthcare infrastructure?
- Which epidemiological trends are expected to influence future drug development and market access strategies for chronic migraine across the 8 major markets?
Scope of the Chronic Migraine Epidemiology Report
- The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic migraine based on several factors.
- Chronic Migraine Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
- The chronic migraine report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.
Related Reports
Pricing Plans
Upto 15% Off
USD
-
$2699 $2429
-
$4299 $3869
-
$5799 $4949
-
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Report Features |
Details |
|
Base Year |
2025 |
|
Historical Period |
2019-2025 |
|
Forecast Period |
2026-2035 |
|
Epidemiology Statistics Provided |
|
|
Segmentation Provided |
|
|
Geographies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
